Bioadaptives Inc (BDPT)

$0.03 +0.00 (10.99%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 194,400
Avg Vol 132,686
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 41%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and c...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 702 659 8829
Address:
2620 Regatta Drive, Suite 102, Las Vegas, United States
profitdaddy
profitdaddy Oct. 14 at 1:31 PM
BioAdaptives, Inc. (OTC: $BDPT) is innovating in the wellness and biotech space — blending plant, algal, and mushroom-based ingredients with medical devices to support human and animal health. Recent product rollouts include MyndMed™ for cognitive support and PawPa™ Regen for pets, signaling the company’s push into both human and animal wellness markets. At current levels (around the $0.05 range) and with micro-cap status, $BDPT represents a high-risk, high-potential-reward opportunity. If you're comfortable with volatility, this is a name to keep on your radar.
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 7 at 6:56 PM
InvestorNewsBreaks – $BDPT Launches MyndMed Cognitive-Support Supplement Following Successful Testing and Strong Early Demand https://ibn.fm/HfeqV
0 · Reply
icefsh
icefsh Oct. 7 at 5:02 PM
$BDPT Yikes! This is going to fly!!
0 · Reply
profitdaddy
profitdaddy Oct. 1 at 2:03 PM
$BDPT- low floater with some good stuff! Definitely under the radar at the moment and a complete steal. IMO, we see .25 by end of the year.
1 · Reply
70mustang
70mustang Sep. 25 at 8:45 PM
$BDPT scam pos company..never answerwd my emails.my dividend shares are still locked up..do not invest in this!
0 · Reply
70mustang
70mustang Aug. 26 at 6:38 PM
$BDPT just emailed the company thru my personal email and thru there website asking what the holdup is with the dividend issued shares back in January..I want to know what the fuck is going on. "Hello, can you please tell me when the dividend shares that were issued to existing shareholders back in January 2025 as a token of your appreciation for holding company shares be able to be traded? I thought it was 6 months after the issue date, which is already well beyond that? Regards," Concerned share holder
1 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 20 at 7:14 PM
BioMedNewsBreaks — $BDPT Receives WADA-Compliant Certification for MyndMed(TM) From TruShield(TM) https://ibn.fm/4b4Xj
0 · Reply
70mustang
70mustang Jul. 29 at 4:42 PM
$BDPT does anyone know when the dividend stock that was ussued back in January will be tradable?
4 · Reply
70mustang
70mustang Jul. 22 at 6:19 PM
$BDPT what happened here today
1 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 17 at 3:01 PM
$BDPT L2 looking thin here watching LT
0 · Reply
Latest News on BDPT
No data available.
profitdaddy
profitdaddy Oct. 14 at 1:31 PM
BioAdaptives, Inc. (OTC: $BDPT) is innovating in the wellness and biotech space — blending plant, algal, and mushroom-based ingredients with medical devices to support human and animal health. Recent product rollouts include MyndMed™ for cognitive support and PawPa™ Regen for pets, signaling the company’s push into both human and animal wellness markets. At current levels (around the $0.05 range) and with micro-cap status, $BDPT represents a high-risk, high-potential-reward opportunity. If you're comfortable with volatility, this is a name to keep on your radar.
0 · Reply
NetworkNewsWire
NetworkNewsWire Oct. 7 at 6:56 PM
InvestorNewsBreaks – $BDPT Launches MyndMed Cognitive-Support Supplement Following Successful Testing and Strong Early Demand https://ibn.fm/HfeqV
0 · Reply
icefsh
icefsh Oct. 7 at 5:02 PM
$BDPT Yikes! This is going to fly!!
0 · Reply
profitdaddy
profitdaddy Oct. 1 at 2:03 PM
$BDPT- low floater with some good stuff! Definitely under the radar at the moment and a complete steal. IMO, we see .25 by end of the year.
1 · Reply
70mustang
70mustang Sep. 25 at 8:45 PM
$BDPT scam pos company..never answerwd my emails.my dividend shares are still locked up..do not invest in this!
0 · Reply
70mustang
70mustang Aug. 26 at 6:38 PM
$BDPT just emailed the company thru my personal email and thru there website asking what the holdup is with the dividend issued shares back in January..I want to know what the fuck is going on. "Hello, can you please tell me when the dividend shares that were issued to existing shareholders back in January 2025 as a token of your appreciation for holding company shares be able to be traded? I thought it was 6 months after the issue date, which is already well beyond that? Regards," Concerned share holder
1 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 20 at 7:14 PM
BioMedNewsBreaks — $BDPT Receives WADA-Compliant Certification for MyndMed(TM) From TruShield(TM) https://ibn.fm/4b4Xj
0 · Reply
70mustang
70mustang Jul. 29 at 4:42 PM
$BDPT does anyone know when the dividend stock that was ussued back in January will be tradable?
4 · Reply
70mustang
70mustang Jul. 22 at 6:19 PM
$BDPT what happened here today
1 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 17 at 3:01 PM
$BDPT L2 looking thin here watching LT
0 · Reply
Newdie999
Newdie999 Jul. 17 at 1:50 PM
$BDPT testing the floor of the hourly LRC. OBV is at the lowest it has been in at least 2 weeks. Maybe we see the floor develop here.
1 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 16 at 5:42 PM
InvestorNewsBreaks – $BDPT Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025 https://ibn.fm/KHwuX
0 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 16 at 3:29 PM
$BDPT green on news L2 looks thin watching.065
0 · Reply
SHEEPWOLF
SHEEPWOLF Jul. 16 at 2:18 PM
$BDPT NeuroRush™: BioAdaptives’ next-gen nootropic! • For professionals & seniors • Promotes mental endurance • Adaptogen-powered • Hits markets in 2025 https://youtu.be/YqVMplo2gVw
0 · Reply
GeraldSmart873
GeraldSmart873 Jul. 16 at 2:05 PM
AITX gets a reorder from a top 25 healthcare provider. $BDPT is still chasing social media buzz with no confirmed contracts or recurring income.
0 · Reply
Newdie999
Newdie999 Jul. 16 at 1:55 PM
$BDPT’s NeuroRush taps a projected 18% CAGR nootropic market, now slated to hit $31B by 2029. This builds on their global wellness angle, pushing into cognitive performance. $BDPT takeaways: – Already in pets, weight‑management, stem‑cell division – This expands reach into human cognitive supplements – Aligns with past clinical trials (e.g. Zeranovia weight‑loss) – Smart‑to‑market strategy: diversify without diluting brand https://www.otcmarkets.com/stock/BDPT/news/BioAdaptives-Announces-National-Launch-of-NeuroRush--A-Cutting-Edge-Adaptogenic-Nootropic-for-Mental-Clarity-Focus-and-R?id=486043 #Wellness #MentalPerformance #GrowthStocks #BDPT
1 · Reply
Newdie999
Newdie999 Jul. 16 at 1:41 PM
$BDPT rolls out NeuroRush™, an adaptogenic nootropic for mental clarity, focus, and resilience—with no stimulants or crashes. Targeted at gamers, professionals, and seniors. $BDPT breakdown: – Based on TCM + Ayurvedic adaptogens – Market: $10B (2021) → $31B by 2029 – Designed to support mitochondrial energy—boosts endurance & focus – Stimulant-free formula avoids caffeine spikes https://www.otcmarkets.com/stock/BDPT/news/BioAdaptives-Announces-National-Launch-of-NeuroRush--A-Cutting-Edge-Adaptogenic-Nootropic-for-Mental-Clarity-Focus-and-R?id=486043 #Nootropic #CognitiveHealth #Adaptogens #BDPT
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 24 at 7:50 PM
InvestorNewsBreaks – $BDPT to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum https://ibn.fm/S7szn
0 · Reply
AmandaBlakes1061
AmandaBlakes1061 Jun. 19 at 2:57 PM
$BDPT is in biotech trials with little commercial proof. AITX already commercializes AI tech with real clients and a growing deployment pipeline.
0 · Reply
ShaunPetri911
ShaunPetri911 Jun. 2 at 5:15 PM
$BDPT AITX's 35 Fortune 500 prospects represent a potential gold mine — each one could lead to multi-unit, multi-year deployments worth millions in recurring revenue. The land-and-expand potential here is enormous, and the SOC 2 certification now removes the last barrier to these enterprise deals.
0 · Reply